An arthritis drug discovered by AI could reduce the risk of elderly people dying from COVID-19, according to a new study. The once-daily medicine, called baricitinib, was first identified as a potential treatment for the virus by BenevolentAI, a startup based in London. The company used its AI software to comb through scientific literature for drugs that might block the infection process. The most promising treatment it discovered was baricitinib, which it predicted could stop the infection from entering lung cells. The new study has now shown the drug’s safety and efficacy in the largest group of patients published thus far.…
This story continues at The Next Web